SEC Filing Summary: pSivida Limited (Form 6-K)
Business Context and Reporting Period
This Form 6-K was filed by pSivida Limited, a foreign issuer headquartered in Perth, Western Australia, on March 16, 2005. The report covers the month of March 2005 and serves to disclose a specific corporate event rather than providing comprehensive financial results.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a corporate announcement and does not contain financial statements or performance metrics.
Material Changes
The material change disclosed in this filing is the addition of pSivida Limited to the Merrill Lynch Nanotechnology Index. No other material changes to operations or financial status are reported in this document.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, risk factors, or discussion of contingencies and unusual items. The sole purpose of the submission is to report the index inclusion.
Key Facts for Investor Verification
- Verify the effective date of pSivida's inclusion in the Merrill Lynch Nanotechnology Index.
- Confirm the impact of this index inclusion on trading volume or liquidity for the company's shares.
- Note that this filing does not contain financial performance data; investors should refer to the company's Form 20-F for financial statements.